Krystal Biotech Shares Outstanding 2017-2024 | KRYS

Krystal Biotech shares outstanding for the quarter ending September 30, 2024 were 0.030B, a 3.5% increase year-over-year.

  • Krystal Biotech 2023 shares outstanding were 0.028B, a 8.87% increase from 2022.
  • Krystal Biotech 2022 shares outstanding were 0.025B, a 14.84% increase from 2021.
  • Krystal Biotech 2021 shares outstanding were 0.022B, a 18.15% increase from 2020.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

Krystal Biotech Shares Outstanding 2017-2024 | KRYS

  • Krystal Biotech 2023 shares outstanding were 0.028B, a 8.87% increase from 2022.
  • Krystal Biotech 2022 shares outstanding were 0.025B, a 14.84% increase from 2021.
  • Krystal Biotech 2021 shares outstanding were 0.022B, a 18.15% increase from 2020.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Related Stocks
Company NameMarket
Cap
Amgen (AMGN)$150.5B
Bristol Myers Squibb (BMY)$118.1B
Vertex Pharmaceuticals (VRTX)$115.4B
Gilead Sciences (GILD)$109.4B
CSL (CSLLY)$85.4B
Regeneron Pharmaceuticals (REGN)$81.8B
GSK (GSK)$69.3B
Argenex SE (ARGX)$34.4B
Alnylam Pharmaceuticals (ALNY)$30.2B
BioNTech SE (BNTX)$25.5B
Biogen (BIIB)$22.6B
Illumina (ILMN)$21.4B
BeiGene (BGNE)$18.3B
Moderna (MRNA)$14.3B
Incyte (INCY)$13.6B
Genmab (GMAB)$13.6B
Insmed (INSM)$13.2B
BioMarin Pharmaceutical (BMRN)$11.8B
Vaxcyte (PCVX)$10.9B
Bio-Techne Corp (TECH)$10.5B
Sarepta Therapeutics (SRPT)$10.2B
Exact Sciences (EXAS)$10B
Exelixis (EXEL)$9.8B
Revolution Medicines (RVMD)$9.5B
Bio-Rad Laboratories (BIO.B)$9.4B
QIAGEN (QGEN)$9.3B
Intra-Cellular Therapies (ITCI)$8.8B
Roivant Sciences (ROIV)$8.4B
Ascendis Pharma (ASND)$7.5B
Repligen (RGEN)$7.2B